Mucus hypersecretion is characteristic of chronic airway diseases. However, regulatory mechanisms are poorly understood. Human airway epithelial cells grown on permeable supports at the air-liquid interface (ALI) develop a mucociliary morphology resembling that found in vivo . Such cultures provide a model for studying secretory cell lineage, differentiation, and function, and may provide insight regarding events leading to mucus hypersecretion. The mucin gene expression profile of well-differentiated human airway epithelial cells in culture has not yet been established. We compared expression of all the currently described mucin genes in poorly differentiated (conventional cultures on plastic) and well-differentiated (ALI) human nasal and bronchial epithelial cells. Differentiation-dependent upregulation of MUC3, MUC5AC, MUC5B, and MUC6 messenger RNA (mRNA) was demonstrated using reverse transcriptase-polymerase chain reaction (RT-PCR). Northern blot analysis showed a similar increase for MUC4 and demonstrated that induction of MUC4 and MUC5B expression depended on retinoic acid. MUC1, MUC2, MUC7, and MUC8 mRNAs were also detected by RT-PCR, but these genes did not appear to be strongly regulated as a function of differentiation. Mucin gene expression was similar in bronchial and nasal cells. Thus, mucociliary differentiation of human airway epithelia in vitro entails upregulation of several mucin genes. 
An overlying mucous layer protects the airway epithelium and traps particulates for mucociliary clearance. This layer is composed primarily of large, gel-forming, oligomeric mucin glycoproteins that are produced by both airway surface goblet cells and submucosal gland mucous cells. In chronic airway diseases such as asthma, chronic bronchitis, and cystic fibrosis, submucosal glands become enlarged (hypertrophy), the number of goblet cells in the airway surface epithelium increases (hyperplasia), and goblet cells appear in distal airways where they are not normally present (metaplasia). As part of the overall disease process, these cellular changes often result in mucus hypersecretion and/or the production of mucus with altered physical properties, which in turn may increase resistance to air flow and impair mucociliary clearance ( see 1, 2, and references therein). In certain cases, the resulting physiologic airway obstruction may lead to chronic infection. A more thorough understanding of mucin gene expression may permit the development of novel therapeutic approaches for treating chronic airway diseases.
To date, nine mucin genes have been identified in humans. Four of these, MUC2, MUC5AC, MUC5B, and MUC6, are clustered at chromosomal location 11p15. 5 and are structurally related (3) . The complete complementary DNA (cDNA) sequence and at least partial genomic structure have been determined for the membrane-bound mucin MUC1 (4, 5) , the intestinal mucin MUC2 (6) (7) (8) , and the small salivary mucin MUC7 (9, 10) .
MUC4 (11) , MUC5AC (12, 13) , MUC5B (14) , and MUC8 (15) were originally cloned from airway epithelial cDNA libraries. MUC1, MUC2, MUC3, MUC6, and MUC7 are also expressed in airway epithelia (16) (17) (18) (19) (20) , although MUC3 and MUC6, strongly expressed in intestine and stomach, respectively, are probably present at very low levels.
The predominant mucins in adult respiratory secretions appear to be MUC5AC and MUC5B (21) (22) (23) (24) . MUC2 is expressed in airway epithelial cells and appears to be regulated by various factors in culture (25) (26) (27) and in certain disease states (7, 28) ; however, it may be a minor component of airway epithelial secretions in most cases (22) . MUC4 is also expressed in airway and may contribute to respiratory secretions. The tissue distribution of the MUC4 messenger RNA (mRNA) has been well characterized (18, 29, 30) , but the MUC4 gene is known only by a 48-base-pair (bp) repeat sequence (11) , and the biochemical nature of the gene product is poorly understood.
Recent technical advances now permit the routine production of human airway epithelial cell cultures with a mucociliary morphology resembling the in vivo epithelium. These culture techniques, together with improved transfection protocols, will facilitate the study of mucosecretory cell differentiation and the control of mucin gene expression. The tissue dissociation process yields primary cells derived principally from the airway surface as opposed to the submucosal glands, and an important consideration is how the cultures compare with the known expression in native adult epithelia, both at the level of gene expression and in the composition of the secreted proteins. A fundamental step in this direction is to define patterns of expression for the mucin genes in the in vitro system.
In the current study, we evaluated gene expression for MUC1-MUC8. We compared mucus-secreting cultures grown on permeable supports at the air-liquid interface (ALI) with cultures grown submerged on tissue-culture plastic and determined the expression patterns of the known mucin genes. The submerged cultures exhibit a relatively uniform morphology when compared with the mucociliary phenotype seen both in native tissues and in cultures grown at the ALI, and are used as examples of un-or predifferentiated airway epithelial cells. We also compared nasal and tracheobronchial cell cultures. We report for the first time the differentiation-and retinoic acid (RA)-dependent expression of MUC4, normally expressed in both bronchi and bronchioles, and MUC5B, a submucosal gland mucin, in cultures of normal human airway cells.
Materials and Methods

Cell Culture
Well-differentiated cultures from passage 1 (p1) or passage 2 (p2) airway epithelial cells were grown using procedures modified as follows from those described by Gray and colleagues (31) . Normal lung and nasal tissues were obtained from patients undergoing thoracic surgery or elective nasal surgical procedures as per Institutional Review Board-approved protocols. Excised airways, from which excess connective tissue had been removed, were rinsed in cold Joklik's minimum essential medium plus antibiotics and then incubated in 0.1% protease (Sigma Type XIV) for 16 to 48 h at 4 Њ C (32-34). Ten percent serum was added to neutralize the protease, and cells were freed by gentle scraping and agitation. The cells were washed, resuspended, counted, and then plated at a density of 1 to 2 ϫ 10 6 cells/100-mm-diameter collagen-coated tissue-culture dish in modified LHC9 medium (35) , termed bronchial epithelial growth medium (BEGM). The modifications included increasing the epidermal growth factor (EGF) concentration to 25 ng/ml, adjusting the RA concentration to 5 ϫ 10 Ϫ 8 M and the gentamicin concentration to 40 g/ml, and adding 0.5 mg/ml bovine serum albumin, 0.8% bovine pituitary extract ( see Reference 36), 50 U/ml penicillin, 50 g/ml streptomycin, and 0.125 g/ml amphotericin. Collagen-coated dishes were prepared by incubating dishes for 2 h at 37 Њ C with 40 g/ml Vitrogen 100 (Collagen Biomaterials, Palo Alto, CA) in distilled water, in such a volume as to give 1 g Vitrogen/cm 2 surface area. The Vitrogen solution was then aspirated, and the dishes were dried and sterilized for 10 min under ultraviolet (UV) light. At approximately 75% confluence, the cells were harvested by trypsinization and subpassaged at a density of 0.1 to 0.25 ϫ 10 6 cells/cm 2 on 24-mm Transwell-COL inserts (T-COL; Costar, Cambridge, MA) in ALI medium. ALI is similar to BEGM except that a 50:50 mixture of LHC Basal and Dulbecco's modified Eagle's medium-H is used as the base, amphotericin and gentamicin are omitted, and the EGF concentration is reduced to 0.5 ng/ ml. Upon reaching confluence (3 to 7 d), the apical surface was rinsed with phosphate-buffered saline, and medium was replaced only in the bottom compartment of the culture. When standard tissue-culture wells (2 ml/well) were used, medium was changed daily; in some cases Deep Well Plates (12 ml/well; Becton Dickinson, Franklin Lakes, NJ) were used and medium was changed twice weekly. For studies of mucin gene expression, RNA was isolated from both near confluent primary cells on plastic and from welldifferentiated p1 or p2 cells grown on T-COL membranes at an ALI for at least 14 d.
Histology
For histologic evaluation, specimens were prepared using one of two methods: ( 1 ) fixation with 2% formaldehyde-2% glutaraldehyde and embedding in glycol methacrylate for 1-to 2-m-thick plastic sections; or ( 2 ) fixation with 1% solution of OsO 4 dissolved in perfluorocarbon (37) followed by direct immersion in 100% ethanol, conventional embedding in epon/araldite resin, and preparation of 0.5-to 1.0-m-thick sections. Richardson's stain was used as per standard protocol.
RNA Isolation
Total RNA was isolated from cultured cells using TRI Reagent (Molecular Research Center, Inc., Cincinnati, OH) according to the manufacturer's instructions. Because of the high mucin content of some samples, we included the optional steps suggested for samples with high carbohydrate levels, and this was found to increase RNA yield and purity. RNA was quantitated spectrophotometrically.
Polymerase Chain Reaction Template Preparation
RNA samples were digested with RQ1 ribonuclease (RNase)-free deoxyribonuclease (DNase) in the presence of RNasin RNase inhibitor (both from Promega, Madison, WI) in the recommended buffer for 30 min at 37 Њ C. The digested material was purified with an RNeasy Mini Prep kit (Qiagen, Chatsworth, CA) using the protocol titled "RNA Cleanup" in the product manual. Integrity of the DNase-treated RNA was verified by running 2 g of each preparation on an ethidium bromide (EBr)-containing agarose gel and visualizing the ribosomal RNA bands with a UV transilluminator.
RNA prepared as described previously was reverse transcribed using Random Primer oligonucleotides and SuperScript II RNase H Ϫ Reverse Transcriptase (both from GIBCO BRL, Grand Island, NY) as per the manufacturer's instructions. To reduce variability between polymerase chain reaction (PCR) reactions, enough first-strand cDNA was made at one time to provide template for all PCR amplifications. PCR conditions were optimized empirically using AmpliTaq Gold DNA polymerase (PerkinElmer, Branchburg, NJ) and a PTC-100 thermal cycler (MJ Research, Inc., Watertown, MA). PCR analysis of the templates with an intron-spanning primer pair for ␥ -actin indicated no detectable DNA contamination ( see Figure  1 ). For each primer pair, the identity of the PCR product was confirmed by digesting with a specific restriction endonuclease to give products of predicted sizes.
For each tissue type and culture condition (bronchial plastic, bronchial T-COL, nasal plastic, nasal T-COL), RNA was pooled from different individuals (4, 12, 4 , and 6 cultures, respectively; equal quantities of RNA from each culture), for a total of four pools. (RNA from these same pools was used for Northern analysis; see below ). To minimize experimental error, all pools were handled identically and processed at the same time. For a given mucin primer pair, all four template pools were amplified simultaneously. Negative controls, consisting of reaction mixtures containing all components except template, were included with each PCR run.
PCR Primers
The primers used are listed in Figure 1 . Primers for MUC1, MUC2 and MUC5AC, and MUC7 were from references (38) , (39) , and (9), respectively. All other primers were designed using GCG Wisconsin Package Software from Genetics Computer Group, Inc. (Madison, WI).
PCR Data Analysis
The linear range of the amplification was determined by sampling the PCR reactions every three cycles, starting at cycle 15 to 21 and continuing through cycle 39. PCR reactions were run on NuSeive agarose gels (FMC BioProducts, Rockland, ME), and the gels were stained with EBr. Digitized images of the gels were obtained using an ImageStore 7500 Gel Documentation System (UVP, Upland, CA) and were analyzed using the public-domain program NIH Image. To compensate for possible irregularity in UV illumination and charged coupled device (CCD) camera sensitivity, gels were positioned consistently on the UV light box before imaging. Once the linear range was determined for a given primer pair, the PCR reactions were run twice more for the appropriate number of cycles. Band intensity varied considerably between the different primer pairs and slightly from run to run for the same primer pair (probably due to variations in EBr staining). Band intensity was normalized for each of the three runs by setting the average intensity of the bands from the four different template pools to "1" and adjusting the values for the bands accordingly. Normalized values from the three runs were averaged, and the standard deviation was calculated as a measure of experimental error. The average values were then standardized with respect to the cyclophilin mRNA content for each of the four pools (standardized relative intensity; see Figure 2 ).
Northern Analysis
Northern analysis was performed according to standard procedures as outlined (40) . For the airway epithelial cell lanes, RNA from multiple cultures was pooled (the same RNA preparations used for PCR analysis). Dermal fibroblast RNA was prepared from cultures of human foreskin fibroblasts. RNA from trachea, intestine, and salivary gland was obtained from Clontech (Palo Alto, CA). After denaturing agarose gel electrophoresis on a 1.2% gel, RNA was transferred to Hybond-N ϩ by capillary transfer. Blots were hybridized in Rapid-hyb solution with 32 Plabeled random primed probes for MUC5AC and MUC5B ( redi -prime; all from Amersham, Arlington Heights, IL) and riboprobe for MUC4 (Riboprobe Gemini System; Promega). MUC5AC was detected using an Eco RI/ Bam HI 547-bp fragment of NP3a (12) (kindly provided by Dr. Mary Rose, Children's Hospital Medical Center, Washington, DC). For detection of MUC5B mRNA, a PCR product from the carboxy terminus of MUC5B (Accession no. S80993, bases 74-586) was TA cloned into the pCRII-TOPO vector (Invitrogen, Carlsbad, CA). Identity and integrity of the cloned fragment were confirmed by DNA sequencing. The MUC4 probe consisted of 75 bases from the tandem repeat region of the MUC4 gene (Accession no. M64594, bases 111-184) cloned into pBluescript as previously described (18) . After hybridization, blots were exposed to BioMax MS film (Eastman Kodak, Rochester, NY).
Results
Recent technical improvements permit the reproducible production of well-differentiated human airway epithelial cell cultures. Dissociated cells are seeded on T-COL membranes and grow to confluence within 3 to 7 d. After confluence, no bulk leakage of medium from the basolateral to the apical surface of the epithelium occurs, and the cells grow at an ALI. By 14 d after confluence, extensive ciliary beating is apparent and collections of mucoid material are often visible on the apical surface. In late stage cultures ( Ͼ 21 d), cells typical of native epithelium, including ciliated, basal, and secretory cells, are apparent (Figure 3) . Well-differentiated cultures often persist for more than 2 mo, but pores eventually form in the epithelia and disrupt barrier function. Primary airway epithelial cells cultured on plastic assume a mostly uniform morphology without recognizable ciliated or secretory cells.
PCR was used to screen nasal and bronchial cell cultures for expression of all described mucins except for the predominantly airway epithelial mucin MUC4 (41), which was screened by Northern blot. For MUC4, the only published nucleotide sequence is from the repetitive region of the gene, which is unsuitable for the design of PCR primers (11) .
For comparative PCR, in which expression levels of a single gene are compared between samples, PCR time courses were generated for all primer pairs to determine the linear range of the PCR reactions. The time courses for the 11p15 cluster mucins, MUC2, MUC5AC, MUC5B, and MUC6, and the standard, cyclophilin, are shown in Figure 2 . These time courses illustrate the expected increase in PCR product quantity.
Cyclophilin was chosen as an internal standard to correct for variations in the starting concentrations of template cDNA. Cyclophilin is a cytosolic protein that binds cyclosporin A, and it also may be involved in protein folding. It is abundant in eukaryotic cells, and the level appears stable in most tissues and cell lines (42) . The levels of cyclophilin mRNA in airway epithelial cells appear to remain constant under conditions that affect the level of MUC2 expression (7) .
Bar graphs comparing expression levels for mucin genes in nasal and bronchial cultures grown on tissue-culture plastic and on T-COL membranes are shown in Figure 4 . Of the primary secreted respiratory mucins, MUC5AC and MUC5B show differentiation-dependent changes in expression, with the level increasing in the T-COL cultures. MUC3 and MUC6 also show this pattern. MUC5B and MUC3 show the most dramatic increases, with approximately 4-fold more signal in T-COL cultures as compared with plastic. MUC1 and MUC7 may have slight increases in expression in T-COL cultures. The level of MUC2 remains fairly constant. For all mucin genes, similar patterns of expression were found in bronchial and nasal epithelial cell cultures.
Northern blot analysis was used to determine the expression pattern for MUC4, and to confirm expression of the important airway mucins MUC5AC and MUC5B. All three of these mucins were detected in nasal and bronchial cells grown on T-COL membranes, but not in those grown on plastic ( Figure 5 ). The high molecular-weight smear seen for these mucins is typical for RNA prepared by conventional methods. Debailleul and associates (43) have demonstrated that this polydispersity is most likely due to mechanical shearing of the very large mRNA transcripts (up to 24 kb), rather than to physiologic mechanisms or nuclease degradation. This would explain the difference in molecular-weight profile seen between the MUC4 and MUC5B signals in Figures 5 and 6 , because the RNA preps used in Figure 6 were handled considerably more than those in Figure 5 . The commercially prepared tracheal RNA also shows more smearing than the RNA prepared from cell cultures in Figure 5 , and this is probably due to differences in preparative technique. As expected from the established tissue distribution, MUC4, MUC5AC, and MUC5B were strongly expressed in human trachea, and were not detected in dermal fibroblasts or intestine.
The time course of MUC4 and MUC5B expression and the RA dependence are shown in Figure 6 . Six days after plating on T-COL membranes, no MUC5B was detected. By 13 d, MUC5B was expressed in the presence of RA. For MUC4, high molecular-weight transcripts also appear by 13 d. The significance of the low molecular-weight smear in the 6-d sample is not clear. Examination of the ribosomal RNA bands indicate that the 6-d RNA sample is not more degraded than samples at the later time points. The band across all lanes at approximately 4.4 kb corresponds in position and intensity to the large ribosomal subunit, and probably represents nonspecific binding of the probe. In the absence of RA, both MUC4 and MUC5B expression were completely suppressed. Figure 7 shows the morphology of the cultures from 6 to 27 d in the presence and absence of RA. Omission of RA results in loss of ciliated and goblet cells and in the development of squamous metaplasia.
Discussion
In the normal human airway, mucus glycoproteins are produced by goblet cells in the surface epithelium and by mucous cells in the submucosal glands. This study is an initial characterization of mucin gene expression patterns in cultures of human airway epithelial cells that in many ways resemble native epithelia. Such primary cell cultures will facilitate the study of mucin gene expression because they more closely mimic the in vivo situation than do most established cell lines. Expression of the MUC2 gene, for example, appears to be at least an order of magnitude lower in some cell lines than in native tissue (8) . Our ultimate goal is to use these cultures for transfections and other manipulations to study airway epithelial cell differentiation and the regulation of mucin gene expression, protein synthesis and glycosylation, and secretion.
Transcripts from all mucin genes tested-MUC1, MUC2, MUC3, MUC5AC, MUC5B, MUC6, MUC7, and MUC8-were detected by PCR in airway cultures, and MUC4 was detected by Northern blot. The respiratory mucins MUC4, MUC5AC, and MUC5B were upregulated in differentiated cultures, whereas MUC2 was not. MUC3 and MUC6, although not considered important respiratory mucins, were also upregulated upon differentiation. Expression patterns for the mucin genes were similar in bronchial and nasal cultures. The upregulation of MUC4 and MUC5B mRNA expression was shown by Northern blot to depend on RA.
All of these mucins have been previously described in the airway (15, 16, 18, 44, 45, 47) . MUC3, a predominantly intestinal mucin, was not detected by Northern blot in cultures similar to these (46) , or by in situ hybridization in normal airway (18) ; however, it is detectable by antibodies in lung tissue (47) and has been shown to be upregulated in lung adenocarcinoma (19) . MUC6 is primarily expressed in the stomach, gallbladder, and intestine, and although it is not detectable by Northern blot in airway, faint staining of the tracheal surface epithelium (but not submucosal glands) has been seen with anti-MUC6 antibodies (20, 48) .
Comparing actual abundance of the different mucin mRNAs is problematic with either PCR or Northern blot techniques because of inherent differences in binding of primers and probes and to the highly complex structures of the mucin genes. Our PCR method was not designed to compare the levels of gene expression of different genes, but rather to compare the expression of a particular gene in different types of cultures. MUC7 and MUC8 are probably expressed at very low levels, as PCR gave faint bands at 39 cycles for these genes. The MUC7 and MUC8 primers gave strong signals with RNA from salivary gland and the lung carcinoma cell line NCI-H292, respectively (not shown), suggesting that the primers are reasonably efficient. These types of assays measure only steady-state levels of mRNA, and therefore may not accurately represent de novo RNA synthesis. The half-lives of MUC2-6 mRNAs have been shown to be well in excess of 12 h in some cell lines (8, 43) , and it is possible that mucin mRNAs synthesized prior to reestablishment of the mucociliary phenotype persist in some cultures. Endotoxin contamination of the medium is also a potential problem. Endotoxin upregulates the MUC2 gene (7), and any dependence of expression on differentiation could be masked if MUC2 has already been induced.
Experimental variability is a common concern when PCR is used to obtain quantitative results. Factors such as reagent variability, inconsistent block temperature, and pipetting errors can contribute to experimental error. In this study, the results of three independent runs were averaged for each primer pair. The standard deviations for these averages were small, indicating that experimental error was not a major problem in these reactions. The higher variability in the MUC7 and MUC8 samples was due to the low intensity of the PCR product bands.
MUC5AC and MUC5B appear to be the primary components of adult airway secretions (21) (22) (23) (24) . Airway mucus is secreted by both the goblet cells of the surface epithelium and the mucous cells of the submucosal glands. Goblet cells and mucous cells are antigenically distinct (13) , and some of the differences may be due to differential expression of mucin genes. MUC5AC is predominantly expressed in surface goblet cells and in some gland neck cells, and MUC5B is expressed by the mucous cells of the glands and in bronchioles (16, 49) . Although MUC4 is expressed in airway epithelia, its contribution to airway secretions has not been determined. MUC4 is circumstantially linked to secretions of the transformed human tracheal gland cell line MM-39, which expresses the MUC4 gene and secretes mucin-like material but does not express MUC2, MUC3, MUC5AC, or MUC5B. However, these cells are cultured on tissue-culture plastic and do not exhibit a well-differentiated morphology (50) .
The method we used to isolate primary cells probably yields predominantly surface rather than gland epithelial cells, so the high level of MUC5B expression suggests changes in gene expression as the epithelium becomes reestablished in culture. Airway epithelial cells are known to have great phenotypic plasticity. For example, serous cells may differentiate into mucosecretory cells after injury, which the dissociation process may mimic (51) . During development, MUC5B mRNA is expressed in both surface tracheal epithelium and developing submucosal glands at 13 wk of gestation, but by 23 wk it is more prominent in the glands (18) . In the adult, MUC5B is expressed in the mucous tubules of the submucosal glands (16) and MUC5AC remains confined to the surface goblet cells (18) . During gland morphogenesis in vivo , specialized RA is required for mucociliary differentiation and for the maintenance of the mucociliary phenotype. In vivo , retinoid deficiency leads to loss of the normal phenotype and development of squamous metaplasia (reviewed in 53). Previous studies in cultured human bronchial epithelial cells have demonstrated that RA is necessary for mucociliary differentiation and for the expression of MUC5AC and MUC2 (25, 31, 39) . The results obtained in the current study for MUC4 and MUC5B are in agreement with the established role of RA in these cells.
Although MUC3 and MUC6 are unlikely to be major secreted mucins in airway epithelial cell cultures, their differentiation-dependent expression is nevertheless intrigu- ing. MUC6 is clustered with MUC2, MUC5AC, and MUC5B (in that order) at chromosomal location 11p15.5 (3). All of these mucin genes except MUC2 show differentiation-dependent regulation in airway epithelial cell cultures. Regulation of this gene cluster is clearly complex, as all four of the mucin genes show different expression patterns in vivo . However, the expression pattern in airway cultures suggests the possibility of some co-regulatory features for the 11p15.5 mucin gene cluster. This type of regulation is also seen for MUC3 (7q22) (54, 55) and MUC4 (3q29) (11, 56) but is not pronounced for MUC1, MUC7, or MUC8, which map to 1q21, 4q13-q21, and 12q24.3, respectively (9, 15, 44). MUC3 and MUC4 may also share some regulatory elements, even though their tissue distributions are different.
This study presents an expression profile for mucin genes in well-differentiated cultures of airway epithelial cells. Companion studies to determine the molecular composition of the secreted mucous layer in these cells are currently in progress. The model provided by these cultures will complement other experimental systems, for example, tracheal xenografts and in vitro developmental models, to further the scope of our knowledge of cell lineage and gene regulation in the airway epithelium. A greater understanding of transcriptional regulation of mucin genes will provide insights into the pathologic processes characteris- tic of chronic airway diseases, and may suggest avenues for therapeutic interventions.
